Kendley announced that Guangdong Kendley Medical Devices Group Co., Ltd., a wholly-owned subsidiary of the company, plans to transfer 7% of its shares in Guangxi Ouwen Medical Technology Group Co., Ltd. to Guangxi Ouwen Holding Group Co., Ltd., Guangxi Ouwen New Era Health Industry Investment Management Partnership, and Guangxi Ouwen New Resonance Health Industry Investment Management Partnership for RMB 52.5 million, respectively. After the transaction is completed, Guangdong Medical Devices Group holds 44% of the shares, and Guangxi Ouwen will no longer be included in the scope of the company's consolidated statements; the transaction was reviewed and approved by the 6th meeting of the 6th board of directors, and there is no need to submit it to the shareholders' meeting for review.

Kendley announced that Guangdong Kendley Medical Devices Group Co., Ltd., a wholly-owned subsidiary of the company, plans to transfer 7% of its shares in Guangxi Ouwen Medical Technology Group Co., Ltd. to Guangxi Ouwen Holding Group Co., Ltd., Guangxi Ouwen New Era Health Industry Investment Management Partnership, and Guangxi Ouwen New Resonance Health Industry Investment Management Partnership for RMB 52.5 million, respectively. After the transaction is completed, Guangdong Medical Devices Group holds 44% of the shares, and Guangxi Ouwen will no longer be included in the scope of the company's consolidated statements; the transaction was reviewed and approved by the 6th meeting of the 6th board of directors, and there is no need to submit it to the shareholders' meeting for review.